Analysis of the band densities revealed that in 41% of the glioma samples, the mRNA level of NEDD4-1 was approximately 2.8 fold higher than that of nontumorous tissues, but these samples had relatively normal CNrasGEF mRNA levels (Figure 6A and 6B). This evidence concerns the gene NEDD4 and central nervous system cancer.